CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 369 enrolled
Drug / intervention
Electronic Brachytherapyprocedure
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT03024866
NCT03024866N/ACompleted
CompareCT.gov

A Multi-Center Retrospective-Prospective Matched Pairs Cohort Study to Assess Long-term Clinical Outcomes of Non-melanoma Skin Cancer Patients Treated With eBx Compared to Non-melanoma Skin Cancer Patients Treated With Mohs Surgery

Xoft, Inc.·observational·Posted Jan 19, 2017·Updated Feb 6, 2025

In Brief

An observational study evaluating Electronic Brachytherapy for Nonmelanoma Skin Cancer. Completed, enrolled 369 participants across 4 sites.

Detailed Summary

This is a retrospective-prospective study design. Patients who completed treatment approximately 3 years (range of 2-4 years) at time of IRB approval of this study will be identified and any existing data in the patient's record will be collected in addition to conducting office visits for long-term follow-up.

Study Details

Study Typeobservational
Allocation--
Masking--
Primary Purpose--
ConditionsNonmelanoma Skin Cancer
CountriesUnited States
CollaboratorsEminence Clinical Research, Inc.

Timeline

N/ACompletedFinished
2017201820192020202120222023202420252026
First PostedJan 19, 2017
Enrollment StartOct 1, 2016
Primary CompletionMar 1, 2017
TodayJul 2, 2026
Enrollment to primary: 5 monthsPosted 9.5 years ago

Interventions

Electronic Brachytherapyprocedure

A group receives High-dose-rate electronic brachytherapy (EBT) which provides a non-surgical treatment option and the other group receives Mohs surgery. This matched-pair cohort study compared the outcomes of treatment with EBT to those of Mohs surgery in patients with NMSC.